Virtus ETF Advisers LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 260 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$125,570
-63.0%
3,301
-11.5%
0.08%
-62.2%
Q2 2023$339,803
-11.9%
3,730
-36.2%
0.20%
-5.2%
Q1 2023$385,668
+29.9%
5,847
+1.8%
0.21%
+36.8%
Q4 2022$296,971
-28.3%
5,743
-5.2%
0.16%
-6.1%
Q3 2022$414,000
+53.3%
6,056
+1.4%
0.16%
+65.0%
Q2 2022$270,000
-39.1%
5,970
-31.6%
0.10%
-49.5%
Q1 2022$443,000
+7.3%
8,7250.0%0.20%
+26.9%
Q4 2021$413,000
+78.0%
8,725
+23.7%
0.16%
+52.9%
Q3 2021$232,000
-52.3%
7,052
-8.3%
0.10%
-49.0%
Q2 2021$486,000
+96.8%
7,693
+33.5%
0.20%
+92.3%
Q1 2021$247,000
-23.8%
5,761
+1.6%
0.10%
-22.4%
Q4 2020$324,000
+8.0%
5,668
-43.0%
0.13%
-14.6%
Q3 2020$300,000
-18.7%
9,947
-12.0%
0.16%
-10.3%
Q2 2020$369,000
+6.0%
11,299
-13.1%
0.18%
+22.4%
Q1 2020$348,000
-23.7%
12,996
-12.7%
0.14%
+90.7%
Q4 2019$456,000
+58.3%
14,888
+24.7%
0.08%
+29.3%
Q3 2019$288,000
-9.7%
11,935
-5.3%
0.06%
-13.4%
Q2 2019$319,000
+13.9%
12,600
-12.1%
0.07%
-88.8%
Q1 2019$280,000
+33.3%
14,338
-9.9%
0.60%
+1555.6%
Q4 2018$210,000
-43.5%
15,906
-23.9%
0.04%
-5.3%
Q3 2018$372,000
-53.3%
20,895
-42.3%
0.04%
-94.6%
Q2 2018$797,00036,2230.70%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 2,503,059$170,959,00029.50%
ACUTA CAPITAL PARTNERS, LLC 554,000$37,838,00016.29%
Avoro Capital Advisors LLC 10,125,000$691,538,00012.78%
Sio Capital Management, LLC 507,700$34,676,00011.02%
Logos Global Management LP 1,300,000$88,790,00010.92%
EcoR1 Capital, LLC 5,183,431$354,028,00010.45%
Cormorant Asset Management, LP 1,478,000$100,947,0007.06%
Finepoint Capital LP 266,090$18,174,0005.98%
Ghost Tree Capital, LLC 275,000$18,783,0005.27%
Boxer Capital, LLC 1,303,700$89,043,0005.01%
View complete list of APELLIS PHARMACEUTICALS INC shareholders